|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2004-08-13 Sale |
2004-08-16 12:06 pm | OSI PHARMACEUTICALS INC | OSIP | GEE EDWIN A (Director) | 7,000 | $54.99 | $384,960 | 3,555 (Direct) | View |
| 2004-05-14 Sale |
2004-05-17 4:40 pm | OSI PHARMACEUTICALS INC | OSIP | GEE EDWIN A (Director) | 10,000 | $78.35 | $783,516 | 3,555 (Direct) |
View |
| 2003-10-01 Sale |
2003-10-03 3:57 pm |
OSI PHARMACEUTICALS INC | OSIP | GEE EDWIN A (Director) | 250 | $0 | $0 | 2,746 (Direct) |
View |
| 2003-08-25 Sale |
2003-08-25 5:10 pm | OSI PHARMACEUTICALS INC | OSIP | GEE EDWIN A (Director) | 2,500 | $35.61 | $89,017 | 2,996 (Direct) |
View |
| 2003-08-19 Sale | 2003-08-21 10:09 am |
OSI PHARMACEUTICALS INC | OSIP | GEE EDWIN A (Director) | 2,500 | $34.81 | $87,024 | 2,996 (Direct) | View |
| 2003-08-14 Sale | 2003-08-18 4:41 pm | OSI PHARMACEUTICALS INC | OSIP | GEE EDWIN A (Director) | 5,000 | $32.26 | $161,322 | 2,996 (Direct) |
View |
| Transaction & Date |
Reported Date | Company | Symbol | Insider Relationship | Shares Traded |
Average Price | Total Amount |
Shares Ownership | Filing |
| 2004-08-13 Exercise | 2004-08-16 12:06 pm | OSI PHARMACEUTICALS INC | OSIP | GEE EDWIN A (Director) | 7,000 | $25.45 | $178,163 | 10,555 (Direct) | View |
| 2004-05-14 Exercise | 2004-05-17 4:40 pm | OSI PHARMACEUTICALS INC | OSIP | GEE EDWIN A (Director) | 10,000 | $20.31 | $203,130 | 13,555 (Direct) |
View |
| 2004-03-17 Option Award | 2004-03-19 4:52 pm | OSI PHARMACEUTICALS INC | OSIP | GEE EDWIN A (Director) | 809 | $0 | $0 | 3,555 (Direct) |
View |
| 2003-08-25 Exercise | 2003-08-25 5:10 pm | OSI PHARMACEUTICALS INC | OSIP | GEE EDWIN A (Director) | 2,500 | $6.75 | $16,875 | 5,496 (Direct) |
View |
| 2003-08-19 Exercise |
2003-08-21 10:09 am | OSI PHARMACEUTICALS INC | OSIP | GEE EDWIN A (Director) | 2,500 | $6.75 | $16,875 | 5,496 (Direct) |
View |
| 2003-08-14 Exercise |
2003-08-18 4:41 pm |
OSI PHARMACEUTICALS INC | OSIP | GEE EDWIN A (Director) | 5,000 | $6.75 | $33,750 | 7,996 (Direct) |
View |
| Transaction & Date |
Reported Date | Exercisable Expiration | Company | Symbol | Insider Relationship | Shares Traded |
Conversion Price | Shares Ownership |
Filing |
| 2004-08-13 Exercise |
2004-08-16 12:06 pm | 2004-03-19 2013-03-18 |
OSI PHARMACEUTICALS INC | OSIP | GEE EDWIN A (Director) | 3,540 | $15.02 | 3,960 (Direct) | View |
| 2004-08-13 Exercise |
2004-08-16 12:06 pm | 2002-03-14 2011-03-13 |
OSI PHARMACEUTICALS INC | OSIP | GEE EDWIN A (Director) | 3,460 | $36.12 | 6,540 (Direct) | View |
| 2004-05-14 Exercise | 2004-05-17 4:40 pm |
2001-03-15 2010-03-14 |
OSI PHARMACEUTICALS INC | OSIP | GEE EDWIN A (Director) | 10,000 | $20.31 | 0 (Direct) | View |
| 2004-03-17 Option Award |
2004-03-19 4:52 pm | 2005-03-17 2014-03-16 |
OSI PHARMACEUTICALS INC | OSIP | GEE EDWIN A (Director) | 7,500 | $38.61 | 7,500 (Direct) |
View |
| 2003-08-25 Exercise |
2003-08-25 5:10 pm |
1999-03-25 2008-03-24 |
OSI PHARMACEUTICALS INC | OSIP | GEE EDWIN A (Director) | 2,500 | $6.75 | 0 (Direct) | View |
| 2003-08-19 Exercise | 2003-08-21 10:09 am | 1999-03-25 2008-03-24 |
OSI PHARMACEUTICALS INC | OSIP | GEE EDWIN A (Director) | 2,500 | $6.75 | 2,500 (Direct) | View |
| 2003-08-14 Exercise | 2003-08-18 4:41 pm | 1999-03-25 2008-03-24 | OSI PHARMACEUTICALS INC | OSIP | GEE EDWIN A (Director) | 5,000 | $6.75 | 5,000 (Direct) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Fri, 09 Jan 2009 05:06:17 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |